What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
The scientist’s investigation covers issues in Glaucoma, Trabecular meshwork, Cell biology, Intraocular pressure and Internal medicine.
His Glaucoma research integrates issues from Disease and Anatomy.
His Trabecular meshwork research is multidisciplinary, relying on both Transforming growth factor, Extracellular matrix and Transfection.
His Cell biology research focuses on Cell culture and how it connects with Cell, Cell type, Receptor expression and Immunology.
Abbot F. Clark has researched Intraocular pressure in several fields, including Phenylbutyrate, Pathology, Unfolded protein response and Optic nerve.
Abbot F. Clark interconnects Endocrinology, Signal transduction and Bone morphogenetic protein in the investigation of issues within Internal medicine.
His most cited work include:
- Identification of a Gene That Causes Primary Open Angle Glaucoma (1196 citations)
- Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. (295 citations)
- Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma (279 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Trabecular meshwork, Cell biology, Glaucoma, Endocrinology and Internal medicine.
His Trabecular meshwork study combines topics from a wide range of disciplines, such as Cell culture, Cell, Molecular biology and Glucocorticoid.
Abbot F. Clark combines topics linked to Lamina with his work on Cell biology.
His biological study spans a wide range of topics, including Intraocular pressure, Optic nerve and Pathology.
His work in Optic nerve tackles topics such as Retina which are related to areas like Retinal.
His studies in Endocrinology integrate themes in fields like Receptor and Bone morphogenetic protein.
He most often published in these fields:
- Trabecular meshwork (37.87%)
- Cell biology (32.54%)
- Glaucoma (33.14%)
What were the highlights of his more recent work (between 2016-2021)?
- Trabecular meshwork (37.87%)
- Cell biology (32.54%)
- Glaucoma (33.14%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Trabecular meshwork, Cell biology, Glaucoma, Optic nerve and Extracellular matrix.
Abbot F. Clark studies Trabecular meshwork, namely Myocilin.
His research on Cell biology often connects related areas such as Cell culture.
His Glaucoma study improves the overall literature in Ophthalmology.
His Retinal ganglion cell study, which is part of a larger body of work in Optic nerve, is frequently linked to Head, bridging the gap between disciplines.
He works mostly in the field of Extracellular matrix, limiting it down to topics relating to Actin and, in certain cases, Cytoskeleton.
Between 2016 and 2021, his most popular works were:
- The many faces of the trabecular meshwork cell. (82 citations)
- CRISPR-Cas9–based treatment of myocilin-associated glaucoma (59 citations)
- Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration. (34 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Trabecular meshwork, Glaucoma, Intraocular pressure, Cell biology and Extracellular matrix.
His research in Trabecular meshwork intersects with topics in Molecular biology, Ocular hypertension and Glucocorticoid.
His Ocular hypertension research is multidisciplinary, incorporating elements of Tissue transglutaminase, Endocrinology and Internal medicine.
His Glaucoma research incorporates elements of Cell culture, Homeostasis, Neural crest and Pathology.
His Intraocular pressure research incorporates themes from Animal model, Disease, Bioinformatics and Normal tension.
His Cell biology research includes elements of NFAT and Anatomy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
